Gain Therapeutics, Inc. - COM (GANX)

Q1 2022 13F Holders as of 3/31/2022

Type / Class
Equity / COM
Number of holders
16
Total Shares
1.16M
Shares change
+106K
Total reported value, excl. options
$4.75M
Value change
+$363K
Put/Call ratio
0
Number of buys
6
Number of sells
-9
Price
$4.09
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.